About 2 results found for searched term "Bevacizumab" (0.121 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M6166 | Bevacizumab | VEGFR/PDGFR |
| bevacizumab；Avastin | ||
| Bevacizumab (anti-VEGF, Avastin) is a humanized anti-VEGF monoclonal antibody that is an inhibitor of VEGF. It binds to, and neutralizes, all human-derived VEGF-A isoforms (and biologically active protein hydrolysis fragments).MW:149 KD. | ||
| M24674 | ABP 215 | VEGFR/PDGFR |
| ABP 215 (Bevacizumab-awwb), a Bevacizumab (Bevacizumab biosimilar, is a humanized IgG1 monoclonal antibody targeting VEGFA (VEGFR). ABP 215 has anticancer effects, and can be used metastatic colorectal cancer (mCRC) research. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
